David Wainson

David Wainson

Life Sciences Expert
David Wainson has a background in science and explores the intersection of biology and healthcare. He is a thought leader in bioethics, genomics, and personalized medicine. David unpacks complex topics in an accessible manner, utilizing case studies and clinical trials as real-world examples of how biology supports advanced patient care.
Why Is Mohave College’s Medical Assisting Accreditation Key?
Workforce Why Is Mohave College’s Medical Assisting Accreditation Key?

The modern healthcare landscape depends on a specialized workforce capable of bridging the gap between high-level clinical diagnostics and the complex administrative logistics of patient management. As outpatient facilities and physician offices become the primary hubs for preventative care, the

Employers' 2026 Health Outlook: Cost Pressure, New Levers
Editorial Employers' 2026 Health Outlook: Cost Pressure, New Levers

Benefits have shifted from a line item to a balance-sheet risk. Medical trend is sticky, pharmacy inflation is accelerating, chronic disease is showing up earlier in life, and workplace expectations are rewriting the talent contract. The organizations that hold cost and risk in check will run

Omani Entrepreneur Develops Advanced Wound Care Platform
Care Omani Entrepreneur Develops Advanced Wound Care Platform

The global healthcare landscape is currently grappling with a silent epidemic as diabetic ulcer cases surge, demanding a radical departure from the stagnant methodologies of traditional wound management. While standard bandages have long served as a rudimentary barrier against infection, they often

FDA Reversal Ends Decades of Misleading micronized progesterone Alarms
Care FDA Reversal Ends Decades of Misleading micronized progesterone Alarms

The sudden silence following the Food and Drug Administration's decision to strike down decades of restrictive labeling on hormone replacement therapy marks a seismic shift in how modern medicine perceives the aging female body. For more than twenty years, a cloud of clinical suspicion hovered

Is Protein Degradation the Future of Targeted Oncology?
Care Is Protein Degradation the Future of Targeted Oncology?

The modern landscape of oncology is shifting away from the temporary blockade of cancer cells toward a more permanent solution that involves the total physical eradication of disease-causing machinery to ensure patients achieve deeper and more durable remissions. This transition marks a fundamental

Exon-Skipping Genetic Therapy – Review
Care Exon-Skipping Genetic Therapy – Review

The dream of correcting genetic "typos" has evolved from a speculative laboratory theory into a tangible lifeline for families facing the most aggressive forms of neuromuscular degeneration. In the specific context of Duchenne muscular dystrophy (DMD), the biological necessity of

Trump Imposes Massive Tariffs on Imported Pharmaceuticals
Care Trump Imposes Massive Tariffs on Imported Pharmaceuticals

The sudden transformation of the American medicine cabinet into a geopolitical battleground has sent shockwaves through the global healthcare economy, fundamentally altering how life-saving treatments reach the patient. As the administration moves to solidify a policy of aggressive healthcare

Modern Approaches to Concussion Care and Rehabilitation
Care Modern Approaches to Concussion Care and Rehabilitation

Navigating the complexities of brain health requires more than just a clinical eye; it demands an understanding of how a single impact can ripple through every system in the human body. Dr. Al Cobb, a specialist in chiropractic neurology and concussion rehabilitation, brings a unique perspective to

What Makes Kresladi a Breakthrough for LAD-I Patients?
Care What Makes Kresladi a Breakthrough for LAD-I Patients?

Introduction The scientific landscape has shifted fundamentally for families grappling with the devastating realities of Leukocyte Adhesion Deficiency Type 1, a condition that once left pediatric patients virtually defenseless against the most common environmental pathogens. For decades, the

Can Gilead Reset the Future of Autoimmune Therapy?
Care Can Gilead Reset the Future of Autoimmune Therapy?

The pharmaceutical industry is currently witnessing a tectonic shift as researchers move away from merely dampening overactive immune systems toward a radical process known as the "immune reset." Gilead Sciences has signaled its commitment to this frontier by executing a $1.7 billion

Loading
Latest Articles

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later